Tofersen

Contact Seller for Price

L'expédition est chargable

Enquire Best Price to Buy Tofersen in India

About API Tofersen:

Qalsody (tofersen) is the first FDA-approved therapy developed for individuals with amyotrophic lateral sclerosis (ALS) associated with mutations in the SOD1 gene. This targeted treatment is designed to address the underlying disease process involved in neurodegeneration and its progression. Granted accelerated approval by the FDA, Qalsody demonstrated a reduction in plasma neurofilament light chain (NfL) levels, a recognized biomarker associated with neuronal damage and injury.

Livraison gratuite sur les commandes de 10000 $!

No-Risk Money Back Guarantee!
No Hassle Refunds
Secure Payments

Guaranteed Safe Checkout

CAS Number: 2088232-70-4

Désignation des marsandises

Packaging: Injection: 100 mg/15 mL (6.7 mg/ml) solution in a single-dose vial

Storage: Store refrigerated between 2°C to 8°C (36°F to 46°F).

Dosage: For dosage information, please visit the General Information section.

Strength: Injection: 100 mg/15 mL (6.7 mg/mL) solution in a single-dose vial.

Commentaires (0)

Examens

There are no reviews yet.

Only logged in customers who have purchased this product may leave a review.

Informations sur le fournisseur

Vendor Information

Store Name: 24/7QualityMeds
Vendor: 24/7QualityMeds
No ratings found yet!

Autres produits

Epcoritamab (Tepkinly/Epkinly)
Oncology Drug Contact Seller for Price
Olverembatinib
Anti Cancer Medicines Contact Seller for Price
Trastuzumab Rezetecan
Anti Cancer Injection Contact Seller for Price
Sacituzumab Tirumotecan
Anti Cancer Injection Contact Seller for Price
Ivonescimab
Anti Cancer Injection Contact Seller for Price
Cadonilimab
Anti Cancer Injection Contact Seller for Price

Enquête sur les produits

Your personal data will be used to support your experience throughout this website, to manage access to your account, and for other purposes described in our privacy policy